Location History:
- Jiangsu, CN (2012 - 2014)
- Shanghai, CN (2016)
- Lianyungang, CN (2020)
Company Filing History:
2 out of 2 
2 out of 159 
1 out of 2 Years Active: 2012-2020
Title: Changan Sun: Innovator in Pharmaceutical Patents
Introduction
Changan Sun is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work primarily focuses on innovative drug formulations and methods that enhance therapeutic efficacy.
Latest Patents
One of his latest patents is for a crystal form of a potassium-competitive acid blocker, specifically 1-[5-(2-fluorophenyl)-1-(pyridine-3-sulfonyl)-1H-pyrrole-3-yl]-N-methyl methylamine fumaric acid salt. This invention relates to a stable and reproducible crystal form that is suitable for drug development. Another significant patent involves a human insulin analog and its acylated derivative, which provides a new therapeutic agent for diabetes mellitus. This patent also includes a preparation method for the insulin analog, showcasing his commitment to advancing diabetes treatment.
Career Highlights
Changan Sun has worked with prominent companies in the pharmaceutical industry, including Wuxi Grandchamp Pharmaceutical Technology Co., Ltd. and Jiangsu Hengrui Medicine Company Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical science.
Collaborations
He has collaborated with notable colleagues such as Yali Wang and Aifeng Lv, further enhancing his research and development efforts in the pharmaceutical sector.
Conclusion
Changan Sun's contributions to pharmaceutical innovations through his patents demonstrate his expertise and dedication to improving healthcare solutions. His work continues to impact the field positively, paving the way for future advancements in drug development.